{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:46Z","timestamp":1787068246606,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.parkreldis.2023.105847","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:52:56Z","timestamp":1694753576000},"page":"105847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-8207","authenticated-orcid":false,"given":"Felipe G.","family":"Ravagnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9042-3319","authenticated-orcid":false,"given":"Hellen P.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-3158","authenticated-orcid":false,"given":"Jersey H.S.","family":"Mau\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur N.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Griesi-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-9232","authenticated-orcid":false,"given":"Fab\u00edola R.","family":"Picosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-1407","authenticated-orcid":false,"given":"Henrique B.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo R.","family":"Catharino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2340-6770","authenticated-orcid":false,"given":"Graziella E.","family":"Ronsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-9573","authenticated-orcid":false,"given":"Patr\u00edcia","family":"de Carvalho Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105847_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105847_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0034-1381736","article-title":"Progressive supranuclear palsy","volume":"34","author":"Golbe","year":"2014","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105847_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.irn.2019.10.013","article-title":"Progressive supranuclear palsy","volume":"149","author":"Giagkou","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105847_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Movement Disorder Society-endorsed, Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria, Movement disorders","volume":"32","author":"Hoglinger","year":"2017","journal-title":"official journal of the Movement Disorder Society"},{"key":"10.1016\/j.parkreldis.2023.105847_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fneur.2020.00180","article-title":"Progressive supranuclear palsy-parkinsonism predominant (PSP-P)-A clinical challenge at the boundaries of PSP and Parkinson's disease (PD)","volume":"11","author":"Alster","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","article-title":"Cellular and pathological heterogeneity of primary tauopathies","volume":"16","author":"Chung","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"\"Don't Phos over Tau\": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in alzheimer's disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"Simic","year":"2016","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105847_bib9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.parkreldis.2023.105847_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fcell.2020.00328","article-title":"In vitro models of neurodegenerative diseases","volume":"8","author":"Slanzi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105847_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3934\/mbe.2021094","article-title":"Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression","volume":"18","author":"Krokidis","year":"2021","journal-title":"Math. Biosci. Eng. : MBE"},{"key":"10.1016\/j.parkreldis.2023.105847_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.reth.2020.11.006","article-title":"iPSC for modeling neurodegenerative disorders","volume":"15","author":"Valadez-Barba","year":"2020","journal-title":"Regenerative therapy"},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105847_bib13","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41380-020-00999-7","article-title":"Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders","volume":"26","author":"de Rus Jacquet","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105847_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12914","article-title":"Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration","volume":"31","author":"Briel","year":"2021","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105847_bib15","doi-asserted-by":"crossref","first-page":"fcad158","DOI":"10.1093\/braincomms\/fcad158","article-title":"Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia","volume":"5","author":"Canals","year":"2023","journal-title":"Brain communications"},{"issue":"11","key":"10.1016\/j.parkreldis.2023.105847_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.stemcr.2021.09.013","article-title":"Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3","volume":"16","author":"Chandrasekaran","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.parkreldis.2023.105847_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep42991","article-title":"Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein","volume":"7","author":"Hallmann","year":"2017","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.parkreldis.2023.105847_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade1282","article-title":"Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines","volume":"9","author":"Licht-Murava","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105847_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/156720509788486590","article-title":"Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?","volume":"6","author":"Lopes","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s004010050665","article-title":"Cell cycle markers in the hippocampus in Alzheimer's disease","volume":"94","author":"Nagy","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2023.105847_bib23","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S146239941000150X","article-title":"Pathological implications of cell cycle re-entry in Alzheimer disease","volume":"12","author":"Bonda","year":"2010","journal-title":"Expet Rev. Mol. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105847_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbadis.2006.10.002","article-title":"Cell division in the CNS: protective response or lethal event in post-mitotic neurons?","volume":"1772","author":"Yang","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.parkreldis.2023.105847_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2020.02.011","article-title":"A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype","volume":"90","author":"Porterfield","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105847_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI200318182","article-title":"Oxidative stress, cell cycle, and neurodegeneration","volume":"111","author":"Klein","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105847_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1091\/mbc.E17-01-0031","article-title":"Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations","volume":"29","author":"Caneus","year":"2018","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105847_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-015-1382-7","article-title":"Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease","volume":"129","author":"van Leeuwen","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.parkreldis.2023.105847_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/tra.12610","article-title":"T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation","volume":"19","author":"Chen","year":"2018","journal-title":"Traffic"},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105847_bib30","first-page":"601","article-title":"Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies, Nature reviews","volume":"17","author":"Stamelou","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105847_bib31","article-title":"Japanese longitudinal biomarker study","volume":"vol. 8","author":"Tsujikawa","year":"2022"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105847_bib32","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.celrep.2014.09.042","article-title":"A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease","volume":"9","author":"Brehme","year":"2014","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-018-0524-2","article-title":"Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease","volume":"6","author":"Zhang","year":"2018","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.parkreldis.2023.105847_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2019.03.016","article-title":"Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis","volume":"703","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2023.105847_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-016-0299-2","article-title":"Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain","volume":"4","author":"Kurbatskaya","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.parkreldis.2023.105847_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.02.004","article-title":"Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis'--a perspective review","volume":"105","author":"Yamashima","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"11","key":"10.1016\/j.parkreldis.2023.105847_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1076","article-title":"Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways","volume":"12","author":"Jang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"10.1016\/j.parkreldis.2023.105847_bib38","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1074\/jbc.M414327200","article-title":"Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases","volume":"280","author":"Choi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.parkreldis.2023.105847_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105737","article-title":"SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-beta oligomers","volume":"169","author":"Norambuena","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105847_bib40","first-page":"328","article-title":"Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain, Laboratory investigation","volume":"85","author":"Zagzag","year":"2005","journal-title":"J. Tech. Meth. Pathol."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105847_bib41","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s11481-013-9480-6","article-title":"Immune players in the CNS: the astrocyte","volume":"8","author":"Jensen","year":"2013","journal-title":"J. Neuroimmune Pharmacol. : the official journal of the Society on NeuroImmune Pharmacology"},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1189\/jlb.0306198","article-title":"S100B binding to RAGE in microglia stimulates COX-2 expression","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.parkreldis.2023.105847_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674739","article-title":"The role of GPNMB in inflammation","volume":"12","author":"Saade","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105847_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-018-1100-1","article-title":"The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor","volume":"15","author":"Neal","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.parkreldis.2023.105847_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.796850","article-title":"Lipids as regulators of cellular senescence","volume":"13","author":"Hamsanathan","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.parkreldis.2023.105847_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.788695","article-title":"Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the cargo?","volume":"14","author":"Estes","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.parkreldis.2023.105847_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105305","article-title":"Palmitoylethanolamide: a natural compound for health management","volume":"22","author":"Clayton","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105847_bib48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2022.02.008","article-title":"Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice","volume":"102","author":"Lama","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.parkreldis.2023.105847_bib49","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1582-4934.2011.01267.x","article-title":"Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide","volume":"15","author":"Scuderi","year":"2011","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105847_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.10680","article-title":"Accuracy of clinical diagnosis of progressive supranuclear palsy, Movement disorders","volume":"19","author":"Osaki","year":"2004","journal-title":"official journal of the Movement Disorder Society"},{"issue":"8","key":"10.1016\/j.parkreldis.2023.105847_bib51","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/mds.27619","article-title":"Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy, movement disorders","volume":"34","author":"Ali","year":"2019","journal-title":"official journal of the Movement Disorder Society"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T22:27:07Z","timestamp":1716157627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"alternative-id":["S1353802023009264"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105847","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105847"}}